Staging and Cytoreductive Surgery for Early, Advanced and Recurrent Ovarian Cancer Via a Combination of Conventional and Robotic-Assisted Laparoscopy: A Hybrid Technique

Nezhat, Farr; Finger, T.; Khalil, Susan

doi:10.1016/j.jmig.2013.08.197

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2016

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Here, we offer another option to resolve limited upper abdominal access through a midline incision, which most surgeons are familiar with and may decrease operating time. Through this incision, the surgeon is also able to palpate the abdominal cavity walls for peritoneal seeding and other tumor masses [16].…”

Section: Discussionmentioning

confidence: 99%

Hand-assisted Robotic Approach for Ovarian Cancer Management

Chan¹,

Chiu²,

Chen³

et al. 2016

Adv Robot Autom

View full text Add to dashboard Cite

Robotic assisted staging surgery has been increasingly employed for a variety of gynecological malignancies such as ovarian, endometrial, and cervical cancers. Here we demonstrate a hand-assisted robotic approach for managing ovarian cancer with large tumor mass and predominantly solid components, where mini-laparotomy is performed followed by robotic surgical staging procedures. In this retrospective descriptive analysis of 29 ovarian cancer patients, admitted from December 2011 to May 2014, who had a large tumor mass (≥ 7 cm) and received laparoscopic surgical staging, traditional robotic surgical staging or hand-assisted robotic procedures, we reviewed for patient demographics, surgical procedures, and perioperative parameters. The results were comparable and we conclude the hand-assisted robotic approach offers a safe and feasible way to perform ovarian cancer surgical staging for patients with large tumor masses.

show abstract

Section: Discussionmentioning

confidence: 99%